Personalised Cancer Vaccine Passes Early Safety Test in Ovarian TrialBy Declan QuinnOctober 16, 2026 A phase 1 Nature Medicine trial found a personalised NeoVax vaccine with nivolumab feasible and acceptably safe in platinum-sensitive ovarian cancer.
